PRINTO papers

Author

Title

Journal Select journal Ann Rheum DisArchives Dis Child Arthritis Care ResArthritis Care Res (Hoboken).Arthritis Res TherArthritis RheumArthritis RheumatolBMJBone Marrow TransplantationClin Exp Rheumatol.Curr Opin RheumatolCurrent Rheumatology ReportsEur J Clin PharmacolEur J PediatrGeorgian Med NewsJ Allergy Clin Immunol PractJ PediatrJ RheumatolJAMALancetLancet Child Adolesc HealthLupusN Engl J MedOrphanet J Rare DisPediatr Rheumatol Online JPediatric RheumatologyRDM openRheumatol IntRheumatologyRheumatology (Oxford)Semin Arthritis RheumWorld J Pediatr

Year Select year 20222021202020192018201720162015201420132012201120102009200820072006200520042003200120001997

Search Reset

Ruperto N, Brunner HI, Synoverska O, Ting TV, Mendoza CA, Spindler A, Vyzhga Y, Marzan K, Grebenkina L, Tirosh I, Imundo L, Jerath R, Kingsbury DJ, Sozeri B, Vora SS, Prahalad S, Zholobova E, Butbul Aviel Y, Chasnyk V, Lerman M, Nanda K, Schmeling H, Tory H, Uziel Y, Viola DO, Posner HB, Kanik KS, Wouters A, Chang C, Zhang R, Lazariciu I, Hsu MA, Suehiro RM, Martini A, Lovell DJ for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG)
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial
Lancet 2021 Nov 27;398(10315):1984-1996
Year: 2021 - -

 Ask for reprints

Related project: Liaisons with pharmaceutical companies